Free Trial
→ The Age of Chaos has begun (From Weiss Ratings) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 5 of 15

Slide 5
Back to 4
Continue to 6
 
Back to 4
Continue to 6
 

Teva Pharmaceutical Industries (NYSE:TEVA)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$24.50 (42.2% Upside)

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries logoTeva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. More about Teva Pharmaceutical Industries
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/28/2025Truist FinancialInitiated CoverageBuy$25.00
5/27/2025Truist FinancialUpgradeStrong-Buy
5/12/2025JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$21.00 ➝ $23.00
5/8/2025Bank of AmericaBoost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
4/28/2025Hsbc Global ResUpgradeStrong-Buy
3/6/2025Bank of AmericaLower Price TargetBuy ➝ Buy$23.00 ➝ $20.00
1/30/2025UBS GroupLower Price TargetBuy ➝ Buy$30.00 ➝ $27.00
1/30/2025BarclaysLower Price TargetOverweight ➝ Overweight$28.00 ➝ $26.00
1/23/2025UBS GroupBoost Price TargetBuy ➝ Buy$28.00 ➝ $30.00
1/17/2025Piper SandlerBoost Price TargetOverweight ➝ Overweight$23.00 ➝ $30.00
Slide 5
Back to 4
Continue to 6
 

More From MarketBeat
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored
7 Defensive Stocks to Shield Your Portfolio from Inflation
Inflation is an unavoidable consequence of a market-based economy. In the best case, inflation is fueled by ...
MarketBeat
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
The 12 Most-Hated Stocks on Wall Street
Wall Street research analysts must be the most optimistic people on earth. They give "buy" ratings to more tha...
MarketBeat
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...
Brownstone Research | Sponsored
7 Massive Growth Stocks to Own for the Next 10 Years
Many investors look to get in on the ground floor of a massive growth stock. For example, in 2024, a stock l...
MarketBeat